Amet N, Wang W, Shen WC (2010) Human growth hormone-transferrin fusion protein for oral delivery in hypophysectomized rats. J Control Release 141(2):177–182. https://doi.org/10.1016/j.jconrel.2009.09.007
Baize N, Monnet I, Greillier L, Quere G, Kerjouan M, Janicot H, Vergnenegre A, Auliac JB, Chouaid C (2017) Second-line treatments of small-cell lung cancers. Expert Rev Anticancer ther 17(11):1033–1043. https://doi.org/10.1080/14737140.2017.1372198
Chong A, Lee S, Yang YA, Song J (2017) The role of Typhoid Toxin in Salmonella Typhi Virulence. Yale J Biol Med 90(2):283–290
Ghadaksaz A, Imani Fooladi AA, Mahmoodzadeh Hosseini H, Nejad Satari T, Amin M (2021) Targeting the EGFR in cancer cells by fusion protein consisting of arazyme and third loop of TGF-alpha: an in silico study. J Biomol Struct Dyn 1–14. https://doi.org/10.1080/07391102.2021.1963318
Gonda DK, Bachmair A, Wunning I, Tobias JW, Lane WS, Varshavsky A (1989) Universality and structure of the N-end rule. J Biol Chem 264(28):16700–16712
Jeong MS, Kim DW, Lee MJ, Lee YP, Kim SY, Lee SH, Jang SH, Lee KS, Park J, Kang TC, Cho SW, Kwon OS, Eum WS, Choi SY (2008) HIV-1 Tat-mediated protein transduction of human brain creatine kinase into PC12 ells. BMB Rep 41(7):537–541. https://doi.org/10.5483/bmbrep.2008.41.7.537
Keshtvarz M, Salimian J, Yaseri M, Bathaie SZ, Rezaie E, Aliramezani A, Norouzbabaei Z, Amani J, Douraghi M (2017) Bioinformatic prediction and experimental validation of a PE38-based recombinant immunotoxin targeting the Fn14 receptor in cancer cells. Immunotherapy 9(5):387–400. https://doi.org/10.2217/imt-2017-0008
Mao Y, Yang D, He J, Krasna MJ (2016) Epidemiology of Lung Cancer. Surg Oncol Clin N Am 25(3):439–445. https://doi.org/10.1016/j.soc.2016.02.001
Mezal EH, Bae D, Khan AA (2014) Detection and functionality of the CdtB, PltA, and PltB from Salmonella enterica Serovar Javiana. Pathog Dis 72(2):95–103. https://doi.org/10.1111/2049-632X.12191
Nagata S (2018) Apoptosis and clearance of apoptotic cells. Annu Rev Immunol 36:489–517. https://doi.org/10.1146/annurev-immunol-042617-053010
Saffarian P, Peerayeh SN, Amani J, Ebrahimi F, Sedighian H, Halabian R, Fooladi AA (2016) TAT-BoNT/A((1)(-)(4)(4)(8)), a novel fusion protein as a therapeutic agent: analysis of transcutaneous delivery and enzyme activity. Appl Microbiol Biotechnol 100(6):2785–2795. https://doi.org/10.1007/s00253-015-7240-7
Structural Genomics C, China Structural Genomics C, Northeast Structural Genomics C, Graslund S, Nordlund P, Weigelt J, Hallberg BM, Bray J, Gileadi O et al (2008) Protein production and purification. Nat Methods 5(2):135–146. https://doi.org/10.1038/nmeth.f.202
Ventura S (2005) Sequence determinants of protein aggregation: tools to increase protein solubility. Microb Cell Fact 4(1):11
Yun J, Lee DG (2018) Bactericidal action of Tat (47–58) peptide via attenuation of cell defense systems. Int J Biochem Cell Biol 105:78–83. https://doi.org/10.1016/j.biocel.2018.10.009
Zhang Y (2008) I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 9:40
Zou L, Peng Q, Wang P, Zhou B (2017) Progress in Research and Application of HIV-1 TAT-Derived cell-penetrating peptide. J Membr Biol 250(2):115–122. https://doi.org/10.1007/s00232-016-9940-z
留言 (0)